Literature DB >> 3256373

The long-term outcome of Maudsley depressives.

A S Lee1, R M Murray.   

Abstract

Eighty-nine consecutive admissions with primary depressive illness were prospectively ascertained and diagnosed in 1965-66 by R. E. Kendell, who also allocated each a position on a neurotic-psychotic continuum on the basis of previous discriminant function analysis. In 1983-84, 94% of the survivors were personally interviewed by a psychiatrist blind to index admission data. Operational outcome criteria were employed and longitudinal data were established for 98% of the series. Mortality risk was doubled overall, and increased sevenfold for women under 40 years at index admission. Less than one-fifth of the survivors had remained well, and over one-third of the series suffered unnatural death or severe chronic distress and handicap. Patients whose index episode marked their first psychiatric contact had a 50% chance of readmission within their lifetime, but those with previous admissions had a 50% chance of readmission within three years. Readmissions occurred even after 12 years of being symptom-free, and conversely patients recovered after as long as 15 years of illness. There was a high incidence of other disorders (schizoaffective disorder, alcoholism, schizophrenia), and only four patients showed pure recurrent unipolar histories. Patients at the psychotic end of the continuum were more likely to be readmitted and to have very poor outcomes.

Entities:  

Mesh:

Year:  1988        PMID: 3256373     DOI: 10.1192/bjp.153.6.741

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  25 in total

1.  Should depression be managed as a chronic disease?

Authors:  G Andrews
Journal:  BMJ       Date:  2001-02-17

2.  Clusters of Behaviors and Beliefs Predicting Adolescent Depression: Implications for Prevention.

Authors:  David Paunesku; Justin Ellis; Joshua Fogel; Sachiko A Kuwabara; Jackie Gollan; Tracy Gladstone; Mark Reinecke; Benjamin W Van Voorhees
Journal:  J Cogn Behav Psychother       Date:  2008-09-01

Review 3.  Dimensionality and the category of major depressive episode.

Authors:  Gavin Andrews; Traolach Brugha; Michael E Thase; Farifteh Firoozmand Duffy; Paola Rucci; Timothy Slade
Journal:  Int J Methods Psychiatr Res       Date:  2007       Impact factor: 4.035

4.  The gastrointestinal tract microbiome, probiotics, and mood.

Authors:  Luis Vitetta; Matthew Bambling; Hollie Alford
Journal:  Inflammopharmacology       Date:  2014-09-30       Impact factor: 4.473

Review 5.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 6.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

Review 7.  Selective serotonin reuptake inhibitors. Assessment for formulary inclusion.

Authors:  B H Guze
Journal:  Pharmacoeconomics       Date:  1996-05       Impact factor: 4.981

8.  Clinical validity of major depression-endogenous subtype in adolescent patients.

Authors:  A Wood; A Moore; R Harrington; D Jayson
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-09       Impact factor: 4.785

9.  Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2004-06-01

10.  The Upper Bavarian longitudinal community study 1975-2004. 2. Long-term course and outcome of depression. A controlled study.

Authors:  Manfred M Fichter; Gabriele Kohlboeck; Norbert Quadflieg
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-27       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.